ERD

Periodic Reporting for period 2 - EU-RESPONSE (European Research and Preparedness Network for Pandemics and Emerging Inf...

Project: EU-RESPONSE

Updated at: 01-10-2024

Show more information

Project acronym EU-RESPONSE

Project website

Project: EU-RESPONSE

Updated at: 13-08-2024

Show more information

Project acronym EU-RESPONSE

Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: les...

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Ensuring quality control in a clinical trial during the COVID-19 pandemic: the experience of the Inserm C20-15 DisCoVeRy...

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Experiences and challenges with the new European Clinical Trials Regulation

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised...

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analy...

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Implementation of a Centralised Pharmacovigilance System in Academic Pan-European Clinical Trials: Experience from EU-Re...

Project: EU-RESPONSE

Updated at: 28-02-2024

Show more information

Project acronym EU-RESPONSE

Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for C...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, contro...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-B--1a and h...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with C...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCo...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Assessing the evidence on remdesivir

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and reco...

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Project: EU-RESPONSE

Updated at: 30-10-2023

Show more information

Project acronym EU-RESPONSE

Resources

Selected filters:

Periodic Reporting for period 2 - EU-RESPONSE (European Research and Preparedness Network for Pandemics and Emerging Inf...

Project website

Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: les...

Ensuring quality control in a clinical trial during the COVID-19 pandemic: the experience of the Inserm C20-15 DisCoVeRy...

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

Experiences and challenges with the new European Clinical Trials Regulation

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised...

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analy...

Implementation of a Centralised Pharmacovigilance System in Academic Pan-European Clinical Trials: Experience from EU-Re...

Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for C...

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, contro...

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-B--1a and h...

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with C...

Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCo...

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

Assessing the evidence on remdesivir

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and reco...

Immunocompromised patients have been neglected in COVID-19 trials: a call for action